Ultrasound Multimodality Examination Improves the Diagnostic Efficiency of Non-Mass-Like Breast Lesions
Abstract
This study is focused on ultrasound multimodality examination, which refers to the combined use of three ultrasound examination modalities, ultrasound (US), acoustic radiation force impulse (ARFI) imaging, and contrast-enhanced ultrasound (CEUS). The purpose of this study is to analyze the value of applying ultrasound multimodality examination in the differential diagnosis of benign and malignant breast non-mass-like lesions (NMLs).
Methods
Cases of breast NMLs were analyzed retrospectively, and the nature of all the lesions was verified by pathological examination. Based on the gray-scale ultrasound image characteristics, the cases were classified into types Ⅰ to Ⅴ, and type Ⅰ and type Ⅱ were further classified into 4 subtypes, Ⅰa, Ⅰb, Ⅱa, and Ⅱb, according to whether there was also calcification, and the proportion of malignant cases in each subtype was statistically analyzed. Logistic regression models of US, US+ARFI, US+CEUS, and US+ARFI+CEUS for the diagnosis of malignant cases were established, ROC curves were drawn, the area under the curve (AUC) was calculated, and comparisons were made accordingly. The detection rate of malignant NMLs without calcification (atypical malignant NMLs) by the combination examination of US, ARFI, and CEUS was analyzed.
Results
A total of 407 cases were included in the study. All subjects were female, aged 22 to 81 years, with the average age being (47.0±11.0) years. There were 220 benign cases and 187 malignant cases. Ranked from the highest to the lowest, the malignancy proportion of the different types was Ⅰb>Ⅱb>Ⅲ>Ⅴ>Ⅰa>Ⅱa>Ⅳ. The malignant proportion of the low echo area with calcification was significantly higher than that of the lesions without calcification. The AUC (95% confidence interval [CI]) for diagnosing malignant cases with the logistic regression models of US, US+ARFI, US+CEUS, and US+ARFI+CEUS were 0.895 (0.862-0.927), 0.908 (0.878-0.937), 0.921 (0.893-0.948), and 0.927 (0.902-0.952), respectively. Comparison of the AUC of the 4 regression models showed significant differences (P<0.001). The detection rate of US for NMLs without calcification was 80.7%. When US was used in combination with ARFI and CEUS, 86.4% of the malignant NMLs lesions without calcification could be detected if the lesion CEUS score was 4 or 5 points or if shear-wave velocity (SWV)≥4.28 m/s.
Conclusion
Breast NMLs with calcification show high risks of malignancy, and a pathological examination is always recommended for a conclusive diagnosis. Ultrasound multimodality examination can improve the diagnostic accuracy of breast NML without calcification.
Keywords: Acoustic radiation force impulse, Contrast-enhanced ultrasound, Ultrasound, Breast lesions, Non-mass-like
Full Text:
PDFReferences
WANG Z L, TANG J, LI J L, et al. Ultrasound diagnosis of non-mass-like breast lesions. Chin J Med Imaging, 2013, 21(1): 13–15. doi: 10.3969/j. issn.1005-5185.2013.01.004.
CHA H, CHANG Y W, LEE E J, et al. Ultrasonographic features of pure ductal carcinoma in situ of the breast: correlations with pathologic features and biological markers. Ultrasonography, 2018, 37(4): 307. doi: 10.14366/usg.17039.
ASSING M A, PATEL B K, KARAMSADKAR N, et al. A comparison of the diagnostic accuracy of magnetic resonance imaging to axillary ultrasound in the detection of axillary nodal metastases in newly diagnosed breast cancer. Breast J, 2017, 23(6): 647–655. doi: 10.1111/tbj. 12812.
LIU X, WANG M H, WANG Q, et al. Diagnostic value of contrast-enhanced ultrasound for sentinel lymph node metastasis in breast cancer: an updated meta-analysis. Breast Cancer Res Treat, 2023, 202(2): 221–231. doi: 10.1007/s10549-023-07063-2.
XIAO X Y, ZHI H, YANG H Y, et al. Initial study of contrast-enhanced ultrasound 5-point scoring system in the diagnosis of breast tumor. Chin J Ultrasonogr, 2012, 21(4): 328–331. doi: 10.3760/cma.j.issn.1004-4477. 2012.04.018.
HSU H H, YU J C, LEE H S, et al. Complex cystic lesions of the breast on ultrasonography: feature analysis and BI-RADS assessment. Eur J Radiol, 2011, 79(1): 73–79. doi: 10.1016/j.ejrad.2009.12.037.
CHI Y R, LlU L, LIU X Y, et al. Application value of conventional ultrasound classification and contrast-enhanced ultrasound in non-mass breast-like lesions. Cancer Res Prev Treat, 2022, 49(10): 1048–1053. doi: 10.3971/j.issn.1000-8578.2022.22.0128.
PARK K W, PARK S, SHON I, et al. Non-mass lesions detected by breast US: stratification of cancer risk for clinical management. Eur Radiol, 2021, 31(3):1693-1706. doi: 10.1007/s00330-020-07168-y.
UEMATSU T. Non-mass-like lesions on breast ultrasonography: a systematic review. Breast Cancer, 2012, 19(4): 295–301. doi: 10.1007/s12282-012-0364-z.
HAN L F. Diagnostic value of multimodal ultrasound and its combined scoring method for non-lump type lesions of the breast. Chongqing: Southwest Medical University, 2018.
LI D D, XU H X, GUO L H, et al. Combination of two-dimensional shear wave elastography with ultrasound breast imaging reporting and data system in the diagnosis of breast lesions: a new method to increase the diagnostic performance. Eur Radiol, 2016, 26(9): 3290–300. doi: 10.1007/s00330-015-4163-8.
WU X X, JIANG Y H, LIU M L, et al. Analysis of ultrasound characteristics of malignant breast non-mass-like lesins and development of a nomogram. J Pract Med, 2023, 39(1): 119–123. doi: 10.3969/j.issn. 1006-5725.2023.01.021.
LI M, LI Q, YIN Q, et al. Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer. Clin Transl Oncol, 2021, 23(4): 709–717. doi: 10.1007/s12094-020-02501-9.
ZHOU Y Y, XIE J, ZHANG B, et al. Diagnostic values of conventional ultrasound, contrast-enhanced ultrasound, mammography, magnetic resonance imaging and their combinations in diagnosing patients with early breast cancer. J Guizhou Med Univ, 2023, 48(2): 172–176. doi: 10. 19367/j.cnki.2096-8388.2023.02.008.
TOZAKI M, ISOBE S, YAMAGUCHI M, et al. Ultrasonographic elastography of the breast using acoustic radiation force impulse technology: preliminary study. Jpn J Radiol, 2011, 29(6): 452–456. doi: 10. 1007/s11604-011-0561-2.
WANG Z, LIU F X, YIN Y H, et al. Virtual touch tissue imaging quantification combined with contrast-enhanced ultrasound in diagnosis of breast primary lymphoma: case report. Chin J Med Imag Tech, 2021, 37(1): 157. doi: 10.13929/j.issn.1003-3289.2021.01.040.
MA D D, WANG T, LIU G Y, et al. Value of correcting the classification of mammography scoring method in distinguishing benign and malignant breast masses. J Changchun Univ Tradit Chin Med, 2023, 39(11): 1262–1265. doi: 10.13463/j.cnki.cczyy.2023.11.019.
YAN Y Q, OU D, NI C, et al. Research progress of contrast-enhanced ultrasound and related new technologies in the diagnosis treatment of breast cancer. Oncoradiology, 2023, 32 (6): 561−566. doi: 10.19732/j.cnki. 2096-6210.2023.06.013.
ZHANG Q K, LENG X L, ZHANG F, et al. Diagnostic value of contrast-enhanced ultrasonography in early-onset breast cancer. Chin J Ultrasound Med, 2015, 31(4): 305–307.
OLENA W, WEI Y. Imaging of breast cancers with predilection for nonmass pattern of growth: invasive lobular carcinoma and DCIS--does imaging capture it all? AJR, 2020, 215(6): 1504–1511. doi: 10.2214/AJR.19. 22027.
Refbacks
- There are currently no refbacks.



